Endometrial cancer risk factors

Jump to navigation Jump to search

Endometrial cancer Microchapters

Home

Patient Information

Overview

Historical perspective

Classification

Pathophysiology

Causes

Differentiating Endometrial cancer from other Diseases

Epidemiology and Demographics

Risk factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Endometrial cancer risk factors On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Endometrial cancer risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Endometrial cancer risk factors

CDC on Endometrial cancer risk factors

Endometrial cancer risk factors in the news

Blogs on Endometrial cancer risk factors

Directions to Hospitals Treating Endometrial cancer

Risk calculators and risk factors for Endometrial cancer risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Endometrial cancer usually occurs in women after menopause, and affects more white women than black women. Black women diagnosed with endometrial cancer are more likely to have more advanced disease at diagnosis, and are more likely to die from endometrial cancer than white women.

Risk Factors

Some of the risk factors for endometrial cancer are:

1. Estrogen Exposure

Estrogen exposure through estrogen-only hormone replacement therapy. A combination estrogen-progestin replacement therapy in post menopausal women, however, has not been shown to increase the risk of endometrial cancer. Beginning to have menstrual periods at an early age also increases the number of years the body is exposed to estrogen and increases a woman's risk of endometrial cancer. Similarly, women who reach menopause at an older age are exposed to estrogen for a longer time and have an increased risk of endometrial cancer. Never being pregnant is also a risk factor for endometrial cancer. Because estrogen levels are lower during pregnancy, women who have never been pregnant are exposed to estrogen for a longer time than women who have been pregnant. This increases the risk of endometrial cancer.[1]

2. Tamoxifen

Tamoxifen is one of a group of drugs called selective estrogen receptor modulators, or SERMs. Tamoxifen is used to prevent breast cancer in women who are at high risk for the disease, but it increases the risk of endometrial cancer. This risk is greater in postmenopausal women.[2]

3. Inherited risk

Hereditary nonpolyposis colon cancer (HNPCC) syndrome is an inherited disorder caused by changes in certain genes. Women who have HNPCC syndrome have a much higher risk of developing endometrial cancer than women who do not have HNPCC syndrome.[3] The inherited genetic condition Cowden syndrome can also cause endometrial cancer. Women with this disorder have a 5–10% lifetime risk of developing endometrial cancer,compared to the 2–3% risk for unaffected women

4. Polycystic ovary syndrome

Women who have polycystic ovary syndrome (a disorder of the hormones made by the ovaries) have an increased risk of endometrial cancer.

5. Body fat

Obesity increases the risk of endometrial cancer. This may be because obesity is related to other risk factors such as estrogen levels, polycystic ovary syndrome, lack of physical activity, and a diet that is high in saturated fats.

6. High blood pressure is also a risk factor.
7. Prior pelvic radiation therapy: Radiation can increase the risk of endometrial cancer by damaging the DNA of cells.
8. Diabetes: Epidemiological data shows that endometrial cancer may be as much as four times more common in women with diabetes.
9. Ovarian tumors: The granulosa-theca cell tumor, one type of ovarian tumor, can produce estrogen and increase the risk of endometrial cancer.

References

  1. Vale CL, Tierney J, Bull SJ, Symonds PR (2012). "Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma". Cochrane Database Syst Rev. 8: CD003915. doi:10.1002/14651858.CD003915.pub4. PMID 22895938.
  2. Staley H, McCallum I, Bruce J (2012). "Postoperative tamoxifen for ductal carcinoma in situ". Cochrane Database Syst Rev. 10: CD007847. doi:10.1002/14651858.CD007847.pub2. PMID 23076938.
  3. Ma J, Ledbetter N, Glenn L (2013). "Testing women with endometrial cancer for lynch syndrome: should we test all?". J Adv Pract Oncol. 4 (5): 322–30. PMC 4093445. PMID 25032011 : 25032011 Check |pmid= value (help).


Template:WikiDoc Sources